Category: News &amp; Announcements

November 23, 2022

In this article we discuss what President Biden’s New Executive Order means for America’s place in the biotech and biomanufacturing fields.

10 November

[Patent Announcement] InVivo Biosystems has officially been issued a patent on WHAM-humanization in the nematode, C. elegans

By:

November 10, 2022

We are excited to announce that the USPTO has issued a patent titled, ‘Transgenic animal phenotyping platform and uses thereof’ to InVivo Biosystems.

15 September

If the New Regulation on the Dietary Supplement Industry were to pass, would your Products be Compliant?

By:

September 15, 2022

15 September

What happens if the Dietary Supplement Listing Act of 2022 passes? What if it doesn’t?

By:

September 15, 2022

31 August

[Press Release] InVivo Biosystems and Thaena Announce Novel Metabolite Research Platform With Compelling Longevity and Healthspan Implications and Outcomes

By:

August 31, 2022

25 August

Review: How a Small Worm is Helping Uncover the Pathogenicity of Gene Variants

By:

Ben Jussila ,

August 25, 2022

29 July

A Natural Fit – Using Zebrafish to Evaluate Natural Compounds for Anti-Inflammatory Properties

By:

Laura Taggart-Murphy ,

July 29, 2022

19 April

Differences Between HDR vs NHEJ

By:

Chesley Johnson ,

April 19, 2022

Summary The CRISPR-Cas9 system has become integral in the toolbelts of genomic scientists, researchers, students, etc. Never has it been so easy to wield a

14 April

The Benefits of Standardizing Zebrafish Diets

By:

Emma Lustig ,

Gianna DeMarco ,

Devon Scallion ,

April 14, 2022

We recently were asked to procure a special zebrafish diet, which got us thinking about zebrafish diets overall. Once we started researching this custom diet,

12 April

A Day in the Life: Lab Tech I

By:

Marilee Hoyle ,

April 12, 2022

Summary: Marilee joined InVivo Biosystems in 2021 after graduating with a BSc in Environmental Science from OSU, in this article she chronicles a day in

31 March

Mistakes And Lessons Learned Part 4: Dosing Worms With Drugs

By:

Dan Richards ,

LeAnn Bowers ,

March 31, 2022

18 January

COVID-19’s Impact on Working Parents

By:

January 18, 2022

While the COVID-19 pandemic has impacted us all, it isn’t a mystery that it has disproportionately impacted parents who have faced added stress, work-from-home

6 December

[Press Release] Lifeist Subsidiary Mikra Cellular Sciences to Launch First Product “CELLF” to Combat Brain Fog and Unlock Healthy Aging, Announces U.S. Patent Application and Pre-Clinical Study

By:

December 6, 2021

– Mikra patent focusing on novel cellular therapeutic targeting systemic fatigue – Mikra partners with InVivo Biosystems for pre-clinical trials to strengthen patent application and generate

11 November

Spotlight on InVivo Biosystems’ Zebrafish Work

By:

November 11, 2021

Recently, the life science operating platform Scispot released its list of the Top 5 Zebrafish CROs in the World, with InVivo Biosystems at the top

21 June

InVivo Biosystems Launches New Formulation Analysis Platform to Aid Healthy-Aging Product Research and Development

By:

June 21, 2021

InVivo Biosystems, an expert in genetic small animal model creation and in-vivo testing, announced the launch of its new InVivo Longevity Platform to analyze the

19 August

Homeschool Science Resources for Parents and Kids

By:

August 19, 2020

4 May

InVivo Biosystems has partnered with Enviral Tech to help you safely return to lab

By:

May 4, 2020

24 April

New NIH Grant awarded to InVivo Biosystems to address critical needs in precision medicine research

By:

Kathryn McCormick ,

April 24, 2020

New NIH Grant awarded to InVivo Biosystems to address critical needs in precision medicine research using the model of C. elegans. The grant, titled “Functional

31 March

NemaMetrix Expands Business to Capitalize on In-vivo Solutions to Help Speed Testing for Critical Disease Therapeutics

By:

March 31, 2020

17 March

COVID-19 UPDATE: Current Offerings/How can we help your lab?

By:

March 17, 2020

17 March

Continuity of business in response to COVID-19

By:

March 17, 2020

17 December

CRISPR Benchmark Report Findings

By:

December 17, 2019

17 October

Reviewers’ Choice Abstract Award at ASHG Goes to Ben Jussila for Demonstrating how Zebrafish Can be Used for Disease Modeling

By:

October 17, 2019

11 October

Bayer and NemaMetrix present C. elegans results at Parasitic Helminths conference in Greece

By:

Janis Weeks, Ph.D. ,

October 11, 2019

How are extreme weather events, such as Hurricane Katrina, spreading heartworms and other parasitic nematodes and what are the implications of their spread?

30 August

The Conservative Bias of Life Scientists [Article Review]

By:

Sophia Bethel ,

August 30, 2019

We review a recent article published in Cell discussing the conservative bias of life scientists and how that negatively impacts the diversity in research.

15 August

C. elegans New Lab Checklist

By:

Sophia Bethel ,

August 15, 2019

Are you starting a new C. elegans lab and feeling overwhelmed with starting from scratch? We want to help make this process as smooth as

29 July

NemaMetrix raises $5 million USD funding and strengthens senior team

By:

July 29, 2019

Investment will be used to further develop the Company’s Precisome platform for functional analysis New investment led by Oregon Venture Fund Dr Stephen Turner

20 May

National Epilepsy Week 2019

By:

May 20, 2019

24 April

DNA Day 2019!

By:

April 24, 2019

25 February

New Milestone! We can now remove over 43,000 bp from C. elegans genomic DNA!

By:

Yoanne Clovis, Ph.D. ,

February 25, 2019

12k, 24k, 36k…we can now precisely remove over 43k bp from C. elegans genomic DNA! Knocking out genes is a commonly used tool for biologists

25 January

Child Neurology Meeting: Bernard Sachs Award to William B. Dobyns and Precision Medicine in Epilepsy Lecture

By:

Chris Hopkins ,

January 25, 2019

The Child Neurology Society honored William (Bill) Dobyns for his highly impactful efforts in characterizing child neurology. In a prolific and highly influential carrier, Bill

29 November

PMWC sits down with NemaMetrix to discuss emerging technologies

By:

November 29, 2018

In preparation for the Precision Medicine World Conference on January 20-23rd, 2019, PMWC took a moment to ask us some questions about the new and

16 November

NemaMetrix wins “Job Creation” Award at Inaugural Innovation and Talent Celebration

By:

November 16, 2018

Thursday November 15th, 2018 – NemaMetrix wins the “Job Creation” Award at the RG Media Company’s inaugural Innovation and Talent Celebration. The event was organized

1 November

KCNQ2 Cures Summit – Patient Family Passion and Involvement

By:

Chris Hopkins ,

November 1, 2018

The passion to find answers is inspiring. I had the good fortune to attend the KCNQ2 Cure Summit 2018. Meeting the patient families and seeing

29 March

My last grant application to the NIH proposing experiments in C. elegans got a perfect score!

By:

March 29, 2018

‘Those of us who have studied invertebrate model organisms throughout our careers have been nervous that NIH study sections will shut the door on our

12 December

NemaMetrix becomes the first “Most Innovative” health startup at Demo Day!

By:

December 12, 2017

NemaMetrix Inc. is the winner of the first “Most Innovative” health startup at Demo Day organized by CBInsights.

12 December

DD News features NemaMetrix in its latest issue on Animal Models of Disease

By:

December 12, 2017

The latest issue of Drug Discovery News (DDNews) features a special report on Animal Models of Disease, highlighting the NemaMetrix/Knudra merger and the value of

28 November

Scientists study how cancer spreads by recording a time-lapse of C. elegans

By:

Matt Beaudet, CEO ,

November 28, 2017

Scientists from Duke University captured the cellular break-ins in C. elegans, a transparent worm that’s often used as a model for human biology. The cellular

14 November

NemaMetrix and Knudra Transgenics announce merger

By:

November 14, 2017

NemaMetrix and Knudra Transgenics announce merger to provide fast genotype-to-phenotype answers. The combined company will operate under NemaMetrix Inc.

2 November

New product releases from NemaMetrix

By:

November 2, 2017

As a young and growing company, we are trying to design and introduce new products that can better serve your research needs. We’d like to

5 June

NemaMetrix Introduces Fluorescent Staining Kits for Improved Phenotyping in model organism C. elegans

By:

June 5, 2017

NemaMetrix, a company developing nematode-based drug development and screening technologies, announced the launch of its first series of RediStain™ fluorescent kits for improved visualization of

26 April

NemaMetrix Inc., An American Innovation Success Story

By:

April 26, 2017

NemaMetrix Inc. was selected as the only company representing the state of Oregon by the Science Coalition in its latest Sparking Economic Growth reports released

26 October

Nemametrix and Knudra Transgenics Join Forces to Expand Sales and Marketing Initiatives

By:

October 26, 2016

Nemametrix Inc., a life sciences startup that created the innovative ScreenChip System for drug screening, mutant phenotyping, and toxicological assessment, has entered into a marketing

20 September

ScreenChip Platform Recognized by the White House

By:

September 20, 2014

The NemaMetrix ScreenChip platform technology was recognized by the White House as one of the breakthrough life science research technologies. CEO Matt Beaudet spoke with

13 April

NemaMetrix announces GAP funding

By:

April 13, 2014

NemaMetrix announces being awarded $249,000 in GAP funding from Oregon Nanoscience and Microtechnologies Institute (ONAMI) to fund “proof-of-concept” work and to fuel development towards

28 January

NemaMetrix Announces NIH funding

By: